The global Cancer Stem Cell Market is projected to expand significantly over the forecast period, reaching an estimated USD 6.58 billion by 2034, up from USD 3.03 billion in 2025, at a CAGR of 9.03% (2026–2034). The growth trajectory reflects strong advancements in targeted therapies and regenerative medicine tailored toward cancer treatment.